Tuberculosis linked to increased risk of cancer, study finds

FHS
April 1, 2024
6:13 pm

A population-wide observational study to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows an association between tuberculosis (TB) and cancer, with those with current or previous TB more likely to have a diagnosis of a variety of cancers, including lung, blood, gynaecological and colorectal cancers.

J&Js Lazcluze/Rybrevant combination obtains European approval to treat NSCLC – Pharmaceutical Technology

Lazcluze and Rybrevant specifically target EGFR mutations that drive tumour growth in certain types of NSCLC. Credit: Sorbetto via Getty Images. Johnson & Johnson’s (J&J)

January 21, 2025

Masimo offered up to $950M for consumer business

Dive Brief: Masimo received a non-binding offer on July 2 from a company prepared to buy its consumer business for a range of from $850 million

July 9, 2024

Glenmark Pharma to divest 75% stake in life sciences unit for $680m

Glenmark Pharma continues to maintain growth across all its crucial markets. Credit: T. Schneider/Shutterstock.com. Glenmark Pharmaceuticals has signed a definitive agreement for the divestiture of a 75%

September 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.